Trends in Early Outpatient Drug Therapy in Pediatric Inflammatory Bowel Disease in Finland: A Nationwide Register-Based Study in 1999–2009

Table 4

Background data related to the systemic drug therapy strategies during the first 6 months of pediatric inflammatory bowel disease (𝑛=471 patients).

	Single		Combinations
Variable	5-ASA		5-ASA + corticosteroid		Azathioprine^a		𝑃 value
	𝑛=131		𝑛=217		𝑛=123
Gender (male), 𝑛 (%)	79	(60.3)	116	(53.5)	71	(57.7)	0.435
Age at IBD diagnosis, mean (SD)	7.5	(3.8)	8.6	(3.9)	9.4	(3.8)	<0.001
Subtype (diagnosis of Crohn’s disease), 𝑛 (%)	45	(34.4)	71	(32.7)	66	(53.6)	<0.001
Time period (years 2008-2009), 𝑛 (%)	38	(29.0)	92	(42.4)	63	(51.2)	0.002

^aWith other medications (e.g., 5-ASA or/and corticosteroid).